McCully CL - Search Results

1

Plasma pharmacokinetics and cerebrospinal fluid penetration of hypericin in nonhuman primates.

Fox E, Murphy RF, McCully CL, Adamson PC. Fox E, et al. Among authors: mccully cl. Cancer Chemother Pharmacol. 2001;47(1):41-4. doi: 10.1007/s002800000188. Cancer Chemother Pharmacol. 2001. PMID: 11221960

2

The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates.

Kim A, McCully C, Cruz R, Cole DE, Fox E, Balis FM, Widemann BC. Kim A, et al. Invest New Drugs. 2012 Apr;30(2):524-8. doi: 10.1007/s10637-010-9585-1. Epub 2010 Nov 12. Invest New Drugs. 2012. PMID: 21072558 Free PMC article.

3

Plasma and cerebrospinal fluid pharmacokinetics of intravenously administered ABT-751 in non-human primates.

Cho SY, Fox E, McCully C, Bauch J, Marsh K, Balis FM. Cho SY, et al. Cancer Chemother Pharmacol. 2007 Sep;60(4):563-7. doi: 10.1007/s00280-006-0402-7. Epub 2006 Dec 23. Cancer Chemother Pharmacol. 2007. PMID: 17187251

4

The plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite (OSI-420) after intravenous administration of erlotinib in non-human primates.

Meany HJ, Fox E, McCully C, Tucker C, Balis FM. Meany HJ, et al. Cancer Chemother Pharmacol. 2008 Aug;62(3):387-92. doi: 10.1007/s00280-007-0616-3. Epub 2007 Oct 12. Cancer Chemother Pharmacol. 2008. PMID: 17932674

5

Plasma and CNS pharmacokinetics of O4-benzylfolic acid (O4BF) and metabolite in a non-human primate model.

Chuk MK, Cole DE, McCully C, Loktionova NA, Pegg AE, Parker RJ, Pauly G, Widemann BC, Balis FM, Fox E. Chuk MK, et al. Cancer Chemother Pharmacol. 2011 Jun;67(6):1291-7. doi: 10.1007/s00280-010-1407-9. Epub 2010 Aug 20. Cancer Chemother Pharmacol. 2011. PMID: 20725726 Free PMC article.

6

The plasma and cerebrospinal fluid pharmacokinetics of the platinum analog satraplatin after intravenous administration in non-human primates.

Marcus L, Murphy R, Fox E, McCully C, Cruz R, Warren KE, Meyer T, McNiff E, Balis FM, Widemann BC. Marcus L, et al. Cancer Chemother Pharmacol. 2012 Jan;69(1):247-52. doi: 10.1007/s00280-011-1659-z. Epub 2011 Jun 26. Cancer Chemother Pharmacol. 2012. PMID: 21706317 Free PMC article.

7

Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates.

Jacobs SS, Fox E, Dennie C, Morgan LB, McCully CL, Balis FM. Jacobs SS, et al. Among authors: mccully cl. Clin Cancer Res. 2005 Feb 15;11(4):1669-74. doi: 10.1158/1078-0432.CCR-04-1807. Clin Cancer Res. 2005. PMID: 15746072

8

Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates.

Jacobs S, McCully CL, Murphy RF, Bacher J, Balis FM, Fox E. Jacobs S, et al. Among authors: mccully cl. Cancer Chemother Pharmacol. 2010 Apr;65(5):817-24. doi: 10.1007/s00280-009-1085-7. Epub 2009 Aug 7. Cancer Chemother Pharmacol. 2010. PMID: 19662415 Free PMC article.

9

The plasma pharmacokinetics and cerebrospinal fluid penetration of the thymidylate synthase inhibitor raltitrexed (Tomudex) in a nonhuman primate model.

Widemann BC, Balis FM, Godwin KS, McCully C, Adamson PC. Widemann BC, et al. Cancer Chemother Pharmacol. 1999;44(6):439-43. doi: 10.1007/s002800051116. Cancer Chemother Pharmacol. 1999. PMID: 10550563

10

Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acid.

Widemann BC, Sung E, Anderson L, Salzer WL, Balis FM, Monitjo KS, McCully C, Hawkins M, Adamson PC. Widemann BC, et al. J Pharmacol Exp Ther. 2000 Sep;294(3):894-901. J Pharmacol Exp Ther. 2000. PMID: 10945838

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters